Bio-Rad Laboratories, Inc. (BIO)
USD 323.94
(-4.12%)
USD 323.94
(-4.12%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -608.26 Million USD | -13.29% |
| 2022 | -4.48 Billion USD | 2.23% |
| 2021 | 5.62 Billion USD | 13.33% |
| 2020 | 5.1 Billion USD | 47.07% |
| 2019 | 2.45 Billion USD | 6.39% |
| 2018 | 674.72 Million USD | 26.82% |
| 2017 | 269.51 Million USD | 5.78% |
| 2016 | 206.4 Million USD | -11.75% |
| 2015 | 299.33 Million USD | -1.04% |
| 2014 | 303.58 Million USD | -5.01% |
| 2013 | 305.25 Million USD | -20.88% |
| 2012 | 404.44 Million USD | 0.05% |
| 2011 | 409.89 Million USD | 5.9% |
| 2010 | 392.9 Million USD | 16.78% |
| 2009 | 334.55 Million USD | 38.5% |
| 2008 | 272.05 Million USD | 21.13% |
| 2007 | 219.74 Million USD | 10.33% |
| 2006 | 229.4 Million USD | 9.78% |
| 2005 | 176.29 Million USD | -10.78% |
| 2004 | 173.74 Million USD | -1.72% |
| 2003 | 189.43 Million USD | 4.83% |
| 2002 | 180.13 Million USD | 2.18% |
| 2001 | 153.32 Million USD | 74.92% |
| 2000 | 110.07 Million USD | 4.55% |
| 1999 | 76.09 Million USD | 113.27% |
| 1998 | 52.12 Million USD | -7.38% |
| 1997 | 46.1 Million USD | -20.91% |
| 1996 | 56.9 Million USD | 6.2% |
| 1995 | 56.4 Million USD | -3.33% |
| 1994 | 53.5 Million USD | 148.35% |
| 1993 | 27 Million USD | 303.33% |
| 1992 | 28.4 Million USD | -82.86% |
| 1991 | 34.2 Million USD | -1.44% |
| 1990 | 34.7 Million USD | 19.66% |
| 1989 | 29 Million USD | 10.69% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 99.8 Million USD | 11.63% |
| 2024 Q3 | 1.38 Billion USD | 133.84% |
| 2024 Q2 | 146.89 Million USD | -594.85% |
| 2023 Q3 | 148.71 Million USD | 4.77% |
| 2023 Q2 | 141.95 Million USD | -4.04% |
| 2023 FY | - USD | -13.29% |
| 2023 Q4 | 150.79 Million USD | 1.39% |
| 2023 Q1 | 147.93 Million USD | -8.02% |
| 2022 Q2 | 159.53 Million USD | -23.31% |
| 2022 Q1 | 208.03 Million USD | 38.0% |
| 2022 FY | - USD | 2.23% |
| 2022 Q4 | 160.82 Million USD | 25.08% |
| 2022 Q3 | 128.57 Million USD | -19.41% |
| 2021 FY | - USD | 13.33% |
| 2021 Q1 | 151 Million USD | -29.57% |
| 2021 Q2 | 158.33 Million USD | 4.86% |
| 2021 Q3 | 189.91 Million USD | 19.94% |
| 2021 Q4 | 150.75 Million USD | -20.62% |
| 2020 Q4 | 214.4 Million USD | 70.67% |
| 2020 Q3 | 125.62 Million USD | 2.71% |
| 2020 Q2 | 122.31 Million USD | 9.95% |
| 2020 Q1 | 111.23 Million USD | 80.25% |
| 2020 FY | - USD | 47.07% |
| 2019 Q2 | 103.25 Million USD | -12.68% |
| 2019 Q4 | 61.71 Million USD | -42.21% |
| 2019 Q1 | 118.24 Million USD | 7.75% |
| 2019 Q3 | 106.78 Million USD | 3.41% |
| 2019 FY | - USD | 6.39% |
| 2018 Q3 | 73.7 Million USD | -21.57% |
| 2018 Q4 | 109.74 Million USD | 48.91% |
| 2018 FY | - USD | 26.82% |
| 2018 Q1 | 89.13 Million USD | -9.77% |
| 2018 Q2 | 93.97 Million USD | 5.43% |
| 2017 Q3 | 83.17 Million USD | 79.14% |
| 2017 Q4 | 98.78 Million USD | 18.76% |
| 2017 Q1 | 60.63 Million USD | 60.34% |
| 2017 FY | - USD | 5.78% |
| 2017 Q2 | 46.43 Million USD | -23.43% |
| 2016 Q4 | 37.82 Million USD | -44.32% |
| 2016 FY | - USD | -11.75% |
| 2016 Q2 | 71.31 Million USD | 16.91% |
| 2016 Q1 | 60.99 Million USD | -36.1% |
| 2016 Q3 | 67.92 Million USD | -4.76% |
| 2015 FY | - USD | -1.04% |
| 2015 Q2 | 79.43 Million USD | 17.19% |
| 2015 Q3 | 33.4 Million USD | -57.95% |
| 2015 Q4 | 95.44 Million USD | 185.75% |
| 2015 Q1 | 67.78 Million USD | -27.65% |
| 2014 FY | - USD | -5.01% |
| 2014 Q4 | 93.69 Million USD | 32.01% |
| 2014 Q2 | 90.41 Million USD | 56.41% |
| 2014 Q1 | 57.8 Million USD | -40.01% |
| 2014 Q3 | 70.97 Million USD | -21.5% |
| 2013 Q1 | 68.24 Million USD | -40.57% |
| 2013 Q2 | 95.11 Million USD | 39.37% |
| 2013 Q3 | 66.69 Million USD | -29.88% |
| 2013 FY | - USD | -20.88% |
| 2013 Q4 | 96.34 Million USD | 44.46% |
| 2012 FY | - USD | 0.05% |
| 2012 Q2 | 73.3 Million USD | -14.22% |
| 2012 Q1 | 85.46 Million USD | -28.06% |
| 2012 Q4 | 114.82 Million USD | 78.77% |
| 2012 Q3 | 64.23 Million USD | -12.38% |
| 2011 FY | - USD | 5.9% |
| 2011 Q3 | 104.3 Million USD | 6.64% |
| 2011 Q2 | 97.81 Million USD | 6.1% |
| 2011 Q4 | 118.8 Million USD | 13.9% |
| 2011 Q1 | 92.19 Million USD | -13.61% |
| 2010 FY | - USD | 16.78% |
| 2010 Q2 | 94.26 Million USD | 3.82% |
| 2010 Q1 | 90.79 Million USD | 51.08% |
| 2010 Q3 | 101.13 Million USD | 7.29% |
| 2010 Q4 | 106.72 Million USD | 5.52% |
| 2009 FY | - USD | 38.5% |
| 2009 Q4 | 60.09 Million USD | -10.8% |
| 2009 Q3 | 67.37 Million USD | -17.16% |
| 2009 Q2 | 81.32 Million USD | 10.25% |
| 2009 Q1 | 73.76 Million USD | -3.08% |
| 2008 Q3 | 75.76 Million USD | -6.53% |
| 2008 FY | - USD | 21.13% |
| 2008 Q4 | 76.1 Million USD | 0.46% |
| 2008 Q1 | 75.87 Million USD | 16.98% |
| 2008 Q2 | 81.05 Million USD | 6.82% |
| 2007 Q4 | 64.86 Million USD | 39.01% |
| 2007 Q2 | 42.25 Million USD | -9.64% |
| 2007 Q1 | 46.76 Million USD | 9.06% |
| 2007 FY | - USD | 10.33% |
| 2007 Q3 | 46.66 Million USD | 10.42% |
| 2006 Q4 | 42.88 Million USD | 30.3% |
| 2006 Q3 | 32.9 Million USD | -34.42% |
| 2006 Q2 | 50.17 Million USD | -10.09% |
| 2006 Q1 | 55.8 Million USD | 30.02% |
| 2006 FY | - USD | 9.78% |
| 2005 FY | - USD | -10.78% |
| 2005 Q4 | 42.92 Million USD | 18.28% |
| 2005 Q3 | 36.28 Million USD | -2.53% |
| 2005 Q2 | 37.23 Million USD | -24.24% |
| 2005 Q1 | 49.14 Million USD | 29.05% |
| 2004 Q2 | 45.97 Million USD | -2.34% |
| 2004 Q4 | 38.07 Million USD | -26.54% |
| 2004 Q3 | 51.83 Million USD | 12.74% |
| 2004 Q1 | 47.08 Million USD | 5.23% |
| 2004 FY | - USD | -1.72% |
| 2003 Q4 | 44.5 Million USD | -0.45% |
| 2003 Q3 | 44.41 Million USD | 0.05% |
| 2003 Q2 | 46.72 Million USD | -17.16% |
| 2003 Q1 | 54.06 Million USD | 27.34% |
| 2003 FY | - USD | 4.83% |
| 2002 FY | - USD | 2.18% |
| 2002 Q4 | 43.97 Million USD | -11.47% |
| 2002 Q3 | 45.71 Million USD | 11.66% |
| 2002 Q2 | 41.5 Million USD | -7.44% |
| 2002 Q1 | 44.25 Million USD | -10.82% |
| 2001 FY | - USD | 74.92% |
| 2001 Q4 | 45.05 Million USD | 52.13% |
| 2001 Q1 | 50.92 Million USD | 180.07% |
| 2001 Q3 | 31 Million USD | -12.17% |
| 2001 Q2 | 36.64 Million USD | -36.04% |
| 2000 Q1 | 39.75 Million USD | -18.07% |
| 2000 Q4 | 25.78 Million USD | 76.03% |
| 2000 Q3 | 25.94 Million USD | -61.62% |
| 2000 Q2 | 29.28 Million USD | -5.99% |
| 2000 FY | - USD | 4.55% |
| 1999 Q1 | 21.93 Million USD | 65.44% |
| 1999 Q3 | 12.8 Million USD | -30.32% |
| 1999 FY | - USD | 113.27% |
| 1999 Q4 | 23.2 Million USD | 219.85% |
| 1999 Q2 | 18.09 Million USD | -16.44% |
| 1998 Q2 | 11.9 Million USD | -58.79% |
| 1998 FY | - USD | -7.38% |
| 1998 Q4 | 14.5 Million USD | 119.35% |
| 1998 Q1 | 18.2 Million USD | 27.27% |
| 1998 Q3 | 7.5 Million USD | -17.33% |
| 1997 Q1 | 14.9 Million USD | -17.32% |
| 1997 FY | - USD | -20.91% |
| 1997 Q4 | 11.5 Million USD | 76.54% |
| 1997 Q3 | 8 Million USD | -30.77% |
| 1997 Q2 | 11.9 Million USD | -20.95% |
| 1996 Q2 | 13.9 Million USD | -29.57% |
| 1996 Q1 | 18.1 Million USD | 26.53% |
| 1996 FY | - USD | 6.2% |
| 1996 Q4 | 14.7 Million USD | 45.53% |
| 1996 Q3 | 13.2 Million USD | -6.11% |
| 1995 Q3 | 12.1 Million USD | 5.6% |
| 1995 Q2 | 13.2 Million USD | -28.98% |
| 1995 FY | - USD | -3.33% |
| 1995 Q1 | 16.9 Million USD | 18.12% |
| 1995 Q4 | 14.1 Million USD | 11.36% |
| 1994 FY | - USD | 148.35% |
| 1994 Q3 | 11.4 Million USD | -22.78% |
| 1994 Q2 | 13 Million USD | -8.14% |
| 1994 Q1 | 15.6 Million USD | 230.77% |
| 1994 Q4 | 13.5 Million USD | 22.13% |
| 1993 FY | - USD | 303.33% |
| 1993 Q1 | 8.5 Million USD | -29.76% |
| 1993 Q3 | 6.2 Million USD | -21.92% |
| 1993 Q4 | 5.1 Million USD | -8.77% |
| 1993 Q2 | 7.1 Million USD | 23.73% |
| 1992 FY | - USD | -82.86% |
| 1992 Q4 | 8.4 Million USD | 121.05% |
| 1992 Q3 | 7 Million USD | 118.54% |
| 1992 Q2 | - USD | -242.36% |
| 1992 Q1 | 13.1 Million USD | 132.26% |
| 1991 FY | - USD | 1.16% |
| 1991 Q3 | 8.2 Million USD | 4.71% |
| 1991 Q1 | 10.9 Million USD | 1.77% |
| 1991 Q2 | 7.6 Million USD | -26.09% |
| 1991 Q4 | 7.5 Million USD | -30.34% |
| 1990 Q3 | 6.8 Million USD | -8.11% |
| 1990 FY | - USD | 23.13% |
| 1990 Q1 | 9.4 Million USD | 70.37% |
| 1990 Q4 | 10.9 Million USD | 66.18% |
| 1990 Q2 | 7.6 Million USD | -19.57% |
| 1989 Q1 | 56.3 Million USD | 144.75% |
| 1989 Q2 | 7.8 Million USD | -85.97% |
| 1989 Q3 | 5.8 Million USD | -25.32% |
| 1989 Q4 | 6.7 Million USD | -8.47% |
| 1989 FY | - USD | 10.2% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Abbott Laboratories | 10.46 Billion USD | 105.813% |
| Allurion Technologies Inc. | -69.03 Million USD | -781.148% |
| Artivion, Inc. | 38.14 Million USD | 1694.738% |
| Avanos Medical, Inc. | 53.2 Million USD | 1243.355% |
| Butterfly Network, Inc. | -124.84 Million USD | -387.22% |
| Butterfly Network, Inc. | -124.84 Million USD | -387.22% |
| Boston Scientific Corporation | 3.45 Billion USD | 117.616% |
| Perspective Therapeutics, Inc. | -14.83 Million USD | -3999.373% |
| CONMED Corporation | 182.18 Million USD | 433.87% |
| Edwards Lifesciences Corporation | 1.76 Billion USD | 134.412% |
| Paragon 28, Inc. | -36.61 Million USD | -1561.291% |
| Glaukos Corporation | -82.11 Million USD | -640.739% |
| Globus Medical, Inc. | 418.23 Million USD | 245.435% |
| Inspire Medical Systems, Inc. | -17.06 Million USD | -3465.445% |
| Integer Holdings Corporation | 282.05 Million USD | 315.652% |
| Medtronic plc | 9.05 Billion USD | 106.717% |
| Nevro Corp. | -78.31 Million USD | -676.74% |
| Owlet, Inc. | -27.48 Million USD | -2112.758% |
| Penumbra, Inc. | 111.99 Million USD | 643.113% |
| Vicarious Surgical Inc. | -69.19 Million USD | -779.097% |
| Smith & Nephew plc | 979 Million USD | 162.131% |
| Sonendo, Inc. | -54.76 Million USD | -1010.621% |
| STERIS plc | 1.41 Billion USD | 143.066% |
| Stryker Corporation | 5.16 Billion USD | 111.788% |
| Vapotherm, Inc. | -34.35 Million USD | -1670.425% |
| Zimmer Biomet Holdings, Inc. | 2.44 Billion USD | 124.838% |